跳至主要内容
临床试验/NCT07725250
NCT07725250招募中不适用

Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial

National Bureau of Economic Research, Inc.1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2026年4月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
3,000
试验地点
1
主要终点
Systolic blood pressure measurement

研究概览

简要总结

This study evaluates a new digital health program that uses artificial intelligence (AI) to help patients lower their blood pressure through personalized lifestyle recommendations. The program collects information about patients' daily habits and blood pressure readings, then uses AI to suggest lifestyle changes that may work best for each person. The study will measure how well this program works across different groups of patients and aims to improve the program design to make it more effective and easier to use. The program will be offered to diverse patients at UC San Diego Health, including people of different ages, genders, races/ethnicities, and economic backgrounds, as part of their regular healthcare services.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stage I-II hypertension (average clinical readings of blood pressure over 140/90)
  • Adequate decisional capacity to make a choice about participating in this research study
  • Fully ambulatory (not requiring assistive device such as a cane, wheelchair, walker, etc.)

排除标准

  • Pregnancy
  • Under age 18 years
  • Institutionalized individuals who are likely to be vulnerable
  • Dependent on supplemental oxygen

结局指标

主要结局

Systolic blood pressure measurement

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验